Who
Lisa M. Giles
Director
Company insider
Files Form 4 as: Director, Milestone Pharmaceuticals; Director, HCW Biologics; Director, GenMark Diagnostics; Director, Durata Therapeutics.
In numbers
- Trades disclosed
- 41
- Buys
- 5
- Sells
- 0
- Bought
- $51K
- Sold
- $0
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 3 Aug 2012
- Last trade
- 10 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jun 2026filed 12 Jun 2026 | MIST Milestone Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —77,000 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | MIST Milestone Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —77,000 at $0.00 | filing |
| 10 Jun 2025filed 12 Jun 2025 | MIST Milestone Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 28 Aug 2024filed 29 Aug 2024 | MIST Milestone Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 14 Jun 2024filed 17 Jun 2024 | HCWB HCW Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 20 Feb 2024filed 22 Feb 2024 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Code A | $50K35,715 at $1.40 | filing |
| 13 Jun 2023filed 15 Jun 2023 | HCWB HCW Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 7 Jun 2023filed 9 Jun 2023 | MIST Milestone Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 5 Jul 2022filed 11 Aug 2022 | MIST Milestone Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 15 Jun 2022filed 17 Jun 2022 | HCWB HCW Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —41,841 at $0.00 | filing |
| 26 Oct 2021filed 28 Oct 2021 | HCWB HCW Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —37,037 at $0.00 | filing |
| 14 Jun 2021filed 29 Jul 2021 | MIST Milestone Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 22 Apr 2021filed 22 Apr 2021 | GenMark Diagnostics | SEC FORM 4 Code U | $2.0M81,572 at $24.05 | filing |
| 22 Apr 2021filed 22 Apr 2021 | GenMark Diagnostics | SEC FORM 4 Code U | $132K5,500 at $24.05 | filing |
| 22 Apr 2021filed 22 Apr 2021 | GenMark Diagnosticsoption or derivative | SEC FORM 4 Code D | —19,062 | filing |
| 18 Feb 2021filed 19 Feb 2021 | GenMark Diagnostics | SEC FORM 4 Code A | —7,782 at $0.00 | filing |
| 1 Oct 2020filed 5 Oct 2020 | MIST Milestone Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 29 May 2020filed 2 Jun 2020 | GenMark Diagnostics | SEC FORM 4 Code A | —13,825 at $0.00 | filing |
| 30 Oct 2019filed 1 Nov 2019 | GenMark Diagnostics | SEC FORM 4 Code A | —528 at $0.00 | filing |
| 31 Jul 2019filed 2 Aug 2019 | GenMark Diagnostics | SEC FORM 4 Code A | —702 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.